Medulloblastoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
<br> | <br> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | A01 | | | |A01=<div style="width: 20em; padding:1em;">''' | {{Family tree | | | | A01 | | | |A01=<div style="width: 20em; padding:1em;">'''Optimal surgical excision'''</div>}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Histopathological analysis'''</div>}} | {{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Histopathological analysis'''</div>}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">''' | {{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Detailed Staging'''</div>}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">''' | {{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Risk stratification'''</div>}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Radiotherapy and chemotherapy'''<br> | {{Family tree | | | | B01 | | | |B01=<div style="width: 20em; padding:1em;">'''Radiotherapy and chemotherapy'''<br> |
Revision as of 03:33, 2 October 2015
Medulloblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Medulloblastoma medical therapy On the Web |
American Roentgen Ray Society Images of Medulloblastoma medical therapy |
Risk calculators and risk factors for Medulloblastoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Medical Therapy
- The algorithm below summarize the management approach for medulloblastoma patients:[1]
Optimal surgical excision | |||||||||||||||||||
Histopathological analysis | |||||||||||||||||||
Detailed Staging | |||||||||||||||||||
Risk stratification | |||||||||||||||||||
Radiotherapy and chemotherapy according to the risk stratification criteria | |||||||||||||||||||
Radiation Therapy
- Radiotherapy is the mainstay of treatment for medulloblastoma.[2]
- Radiotherapy for medulloblastoma must be started within 6 weeks following surgery.
- The main radiotherapy techniques used in the management of medulloblastoma patients include:
- Conventional radiotherapy technique
- Intensity modulated radiotherapy technique
- Three dimensional radiotherapy technique
- Three dimensional radiotherapy technique demonstrated better outcomes when compared to conventional and intensity modulated radiotherapy techniques.
- As medulloblastoma tends to spread along the cerebrospinal fluid, it is recommended to deliver a craniospinal irradiation with a boost to the posterior fossa.
Chemotherapy
References
- ↑ von Hoff K, Rutkowski S (2012). "Medulloblastoma". Curr Treat Options Neurol. 14 (4): 416–26. doi:10.1007/s11940-012-0183-8. PMID 22622599.
- ↑ Bartlett F, Kortmann R, Saran F (2013). "Medulloblastoma". Clin Oncol (R Coll Radiol). 25 (1): 36–45. doi:10.1016/j.clon.2012.09.008. PMID 23245832.